QQ客服 官方微博 反馈留言

	Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
	Xia, Jinjing; Bai, Hao; Yan, Bo; Li, Rong; Shao, Minhua; Xiong, Liwen; Han, Baohui
刊名	ONCOTARGET
	2017
卷号	8期号:65
关键词	epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) BIM deletion polymorphism erlotinib ABT-737
ISSN号	1949-2553
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3614528
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Xia, Jinjing,Bai, Hao,Yan, Bo,et al. Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer[J]. ONCOTARGET,2017,8(65).
APA	Xia, Jinjing.,Bai, Hao.,Yan, Bo.,Li, Rong.,Shao, Minhua.,...&Han, Baohui.(2017).Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer.ONCOTARGET,8(65).
MLA	Xia, Jinjing,et al."Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer".ONCOTARGET 8.65(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。